IOL Chemicals & Pharmaceuticals has received a formal declaration from its promoter confirming that no encumbrance was created on the company's shares held by the promoter or promoter group, directly or indirectly, during the financial year ended 31st March 2026. The declaration was submitted by Varinder Gupta, Promoter of IOL Chemicals and Pharmaceuticals Ltd, from Ludhiana, and was addressed to the National Stock Exchange of India Ltd, BSE Limited, and the company's Audit Committee.

Declaration Under SEBI Regulation 31(4)

The declaration was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters and members of the promoter group to submit an annual declaration confirming the encumbrance status of their shareholding in the listed company. The submission was dated 6th April 2026 and pertains to the financial year ended 31st March 2026.

Promoter and Promoter Group Entities Covered

The declaration covers the following entities on whose behalf it has been submitted:

Key Details of the Submission

The following table summarises the key parameters of the regulatory submission:

The declaration confirms that none of the shares held by the listed promoter and promoter group entities in IOL Chemicals and Pharmaceuticals Ltd were subject to any encumbrance, whether direct or indirect, during the relevant financial year. The submission was made to both major stock exchanges—NSE and BSE—as well as to the company's Audit Committee, in compliance with applicable SEBI regulations.

IOL Chemicals & Pharmaceuticals Limited has submitted its quarterly compliance certificate for Structured Digital Database (SDD) to both the National Stock Exchange of India and BSE Limited on 17th April 2026. The certificate pertains to the quarter ended 31st March 2026 and demonstrates the company's adherence to regulatory requirements under SEBI's Prohibition of Insider Trading Regulations.

Regulatory Compliance Framework

The compliance certificate was filed pursuant to Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Sr Vice President Abhay Raj Singh, serving as the Compliance Officer, certified the company's full compliance with SDD requirements.

Key Compliance Parameters

The certificate confirms IOL Chemicals and Pharmaceuticals Limited meets all essential SDD requirements:

Event Tracking and Performance

During the quarter ended 31st March 2026, the company was required to capture 1 event and successfully recorded 1 event, achieving 100.00% compliance rate. This demonstrates effective implementation of the company's insider trading prevention mechanisms.

Non-Compliance Status

The compliance certificate reported zero non-compliance issues for the quarter:

Corporate Governance Excellence

The timely submission of the SDD compliance certificate reflects IOL Chemicals and Pharmaceuticals Limited's commitment to maintaining high standards of corporate governance and regulatory compliance. The company's robust internal control systems ensure proper handling of Unpublished Price Sensitive Information (UPSI) and adherence to SEBI's insider trading prevention framework.

The certificate was digitally signed and submitted from the company's Ludhiana office, maintaining transparency in corporate communications with stock exchanges and regulatory authorities.